Illumina

Senior Territory Account Manager

Beijing, China

Not SpecifiedCompensation
Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Life Sciences, Biotechnology, SalesIndustries

Requirements

Candidates should possess a Bachelor's degree and have at least 7 years of experience in sales, with a strong preference for experience in the life sciences or biotechnology industries. Familiarity with driving sales in Beijing, HeiLongJiang, JiLin, Liaoning and Neimenggu provinces is required, along with the ability to develop high value customer accounts and utilize a CRM database effectively.

Responsibilities

The Senior Territory Account Manager will represent the company professionally, ethically, and morally, develop high value customer accounts through the sale of Illumina’s products and services, participate in all sales activities, coordinate and communicate sales strategies, develop and maintain account details in the CRM database, provide sales forecasts, assist with territory planning, maintain relationships with internal customers and product development groups, establish a comprehensive user database, identify trends in usage, spend at least 40% of their time in the field, negotiate genetic analysis sales, assist in identifying new sales people, aid in the development of new territories, and assist with workshops and marketing activities.

Skills

Sales
CRM
Account Management
Territory Management
Negotiation
Genetic Analysis
User Database Development
Sales Forecasting

Illumina

Supports genomics startups through funding and resources

About Illumina

Illumina focuses on fostering innovation in the genomics industry by supporting startups through its Illumina Accelerator program. This program helps entrepreneurs create, launch, and grow genomics-focused companies by providing funding and resources. The accelerator operates in two main locations: the San Francisco Bay Area and Cambridge, UK. Illumina Accelerator has successfully invested in 68 genomics startups, which have collectively raised over $1 billion in venture capital. What sets Illumina apart from its competitors is its strong partnership with leading venture capital investors and its dedicated focus on the genomics sector. The goal of Illumina is to build a thriving ecosystem for genomics innovation, enabling new companies to emerge and advance the field.

Key Metrics

San Diego, CaliforniaHeadquarters
1998Year Founded
$27.2MTotal Funding
IPOCompany Stage
Venture Capital, BiotechnologyIndustries
5,001-10,000Employees

Risks

Over-reliance on NVIDIA's AI technology may limit flexibility in AI solution adoption.
Standardizing proteomics data across platforms could challenge Illumina's data reliability.
Single-flow-cell NovaSeq X System might cannibalize sales of higher-end models.

Differentiation

Illumina leads in genomic sequencing with advanced AI integration and multiomic data analysis.
The company offers innovative array-based solutions for DNA, RNA, and protein analysis.
Illumina's global expansion includes a new Global Capability Center in Bengaluru.

Upsides

Collaboration with NVIDIA enhances drug discovery and clinical development through AI integration.
Pilot proteomics program with UK Biobank aims to generate crucial reference datasets.
Single-cell sequencing kits make high-throughput sequencing accessible to smaller labs.

Land your dream remote job 3x faster with AI